BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34975305)

  • 21. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients.
    Qian XH; Liu XL; Chen SD; Tang HD
    Front Immunol; 2022; 13():986346. PubMed ID: 36159817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer's Disease.
    Liu Z; Li H; Pan S
    Front Genet; 2021; 12():658323. PubMed ID: 34276768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatic Analysis and Experimental Validation of Ubiquitin-Proteasomal System-Related Hub Genes as Novel Biomarkers for Alzheimer's Disease.
    Zhang Y; Wu J; You G; Guo W; Wang Y; Yu Z; Geng Y; Zhong Q; Zan J; Zheng L
    J Integr Neurosci; 2023 Oct; 22(6):138. PubMed ID: 38176925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis.
    Xu J; Gou S; Huang X; Zhang J; Zhou X; Gong X; Xiong J; Chi H; Yang G
    Curr Alzheimer Res; 2023; 20(9):618-635. PubMed ID: 38141185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Effective Diagnostic Biomarkers and Immune Cell Infiltration in Atopic Dermatitis by Comprehensive Bioinformatics Analysis.
    Li C; Lu Y; Han X
    Front Mol Biosci; 2022; 9():917077. PubMed ID: 35911963
    [No Abstract]   [Full Text] [Related]  

  • 26. lncRNA-associated ceRNA network revealing the potential regulatory roles of ferroptosis and immune infiltration in Alzheimer's disease.
    Tan Y; Tang W; Xiao W; Huang R; Li X; Peng W; Yan K; Cao Y; Zeng Y; Kang J
    Front Aging Neurosci; 2023; 15():1105690. PubMed ID: 36875702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Autophagy-Related Candidate Genes in the Early Diagnosis of Alzheimer's Disease and Exploration of Potential Molecular Mechanisms.
    Wang J; Huo X; Zhou H; Liu H; Li X; Lu N; Sun X
    Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38329682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune abnormalities and differential gene expression in the hippocampus and peripheral blood of patients with Alzheimer's disease.
    Wang X; Wang D; Su F; Li C; Chen M
    Ann Transl Med; 2022 Jan; 10(2):29. PubMed ID: 35282083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of immune-related key genes in Alzheimer's disease.
    Wu Y; Liang S; Zhu H; Zhu Y
    Bioengineered; 2021 Dec; 12(2):9610-9624. PubMed ID: 34719321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of immunogenic cell death-related genes involved in Alzheimer's disease.
    Wang R; Du Y; Shao W; Wang J; Liu X; Xu X; Chen G; Sun Y
    Sci Rep; 2024 Feb; 14(1):3786. PubMed ID: 38360834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of oxidative stress-related genes differentially expressed in Alzheimer's disease and construction of a hub gene-based diagnostic model.
    Zhang Y; Kiryu H
    Sci Rep; 2023 Apr; 13(1):6817. PubMed ID: 37100862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Potential Therapeutic Targets of Alzheimer's Disease By Weighted Gene Co-Expression Network Analysis.
    Zhang F; Zhong SR; Yang SM; Wei YT; Wang JJ; Huang JL; Wu DP; Zhong ZG
    Chin Med Sci J; 2020 Dec; 35(4):330-341. PubMed ID: 33413749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the common gene signatures and pathogeneses of obesity with Alzheimer's disease
    Li T; Qu J; Xu C; Fang T; Sun B; Chen L
    Front Endocrinol (Lausanne); 2022; 13():1072955. PubMed ID: 36568118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
    Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S
    J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of dysregulated genes and pathways of different brain regions in Alzheimer's disease.
    Wang Y; Wang Z
    Int J Neurosci; 2020 Nov; 130(11):1082-1094. PubMed ID: 32019384
    [No Abstract]   [Full Text] [Related]  

  • 36. Integrated analysis and identification of hub genes as novel biomarkers for Alzheimer's disease.
    Zhao K; Zhang H; Wu Y; Liu J; Li X; Lin J
    Front Aging Neurosci; 2022; 14():901972. PubMed ID: 36110430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key genes related to immune cells in patients with gram-negative sepsis based on weighted gene co-expression network analysis.
    Zhu D; Zhu K; Guo S
    Ann Transl Med; 2022 Jul; 10(14):787. PubMed ID: 35965814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary exploration of the co-regulation of Alzheimer's disease pathogenic genes by microRNAs and transcription factors.
    Zhang Q; Yang P; Pang X; Guo W; Sun Y; Wei Y; Pang C
    Front Aging Neurosci; 2022; 14():1069606. PubMed ID: 36561136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Profiling of Parkinson's Disease Revealed Its Association With a Subset of Infiltrating Cells and Signature Genes.
    Zhang X; Shao Z; Xu S; Liu Q; Liu C; Luo Y; Jin L; Li S
    Front Aging Neurosci; 2021; 13():605970. PubMed ID: 33633562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.